Inari Medical Announces the Release of 2022 Ethos and Sustainability Report
25 Maio 2023 - 5:01PM
Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device
company with a mission to treat and transform the lives of patients
suffering from venous and other diseases, today announced the
publication of its 2022 Ethos and Sustainability Report. The report
highlights Inari’s commitment to its ethos and important
corresponding environmental, social and governance (ESG)
initiatives. The report can be found on Inari’s website here.
“We are proud to issue our second annual Ethos and
Sustainability Report as we strive to continue to expand our ESG
policies and programs,” said Drew Hykes, CEO of Inari Medical.
“During 2022, we again focused our ESG initiatives on activities
that supported our ethos: putting patients first, making no small
plans, and taking care of each other. Through these efforts, we
have continued to align our corporate initiatives with our
corporate mission. 2022 was a great year for Inari, our patients,
and our employees. Our 2022 Ethos and Sustainability Report
reflects the responsibility that we feel to all our
stakeholders.”
Inari’s ESG initiatives are overseen by the nominating and
corporate governance committee of the company’s board of
directors.
About Inari Medical, Inc.
Patients first. No small plans. Take care of each other. These
are the guiding principles that form the ethos of Inari Medical. We
are committed to improving lives in extraordinary ways by creating
innovative solutions for both unmet and underrecognized health
needs. In addition to our purpose-built products, we leverage our
capabilities in education, clinical research, and program
development to improve patient outcomes. We are passionate
about our mission to establish our treatments as the standard of
care for venous thromboembolism and beyond. We are just getting
started.
Forward Looking Statements
Statements in this press release may contain “forward-looking
statements” that are subject to substantial risks and
uncertainties. Forward-looking statements contained in this press
release may be identified by the use of words such as “may,”
“will,” “should,” “expect,” “plan,” “anticipate,” “could,”
“intend,” “target,” “project,” “contemplate,” “believe,”
“estimate,” “predict,” “potential” or “continue” or the negative of
these terms or other similar expressions, and include, but are not
limited to, statements regarding ESG initiatives, goals and
performance. Any forward-looking statements are based on Inari’s
current expectations, forecasts, and assumptions and are subject to
a number of risks and uncertainties that could cause actual
outcomes and results to differ materially and adversely from those
set forth in or implied by such forward-looking statements. These
risks and uncertainties include, but are not limited to, risks and
uncertainties related to market conditions and satisfaction of
customary closing conditions related to the public offering. For a
discussion of other risks and uncertainties, and other important
factors, any of which could cause our actual results to differ from
those contained in the forward-looking statements, see the section
entitled "Risk Factors" in Inari’s most recent Annual Report on
Form 10-K and its other reports filed with the SEC. Forward-looking
statements contained in this announcement are based on information
available to Inari as of the date hereof and are made only as of
the date of this release. Inari undertakes no obligation to update
such information except as required under applicable law. These
forward-looking statements should not be relied upon as
representing Inari’s views as of any date subsequent to the date of
this press release. In light of the foregoing, investors are urged
not to rely on any forward-looking statement in reaching any
conclusion or making any investment decision about any securities
of Inari.
Investor Contact:Westwicke PartnersCaroline
CornerPhone +1-415-202-5678caroline.corner@westwicke.com
Inari Medical (NASDAQ:NARI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Inari Medical (NASDAQ:NARI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024